By MICHAEL KENNEDYThe Centers for Disease Control and Prevention (CDC) is warning that the use of a spray may be the best way to treat ulcerated COVID patients.
The agency issued the warning on Thursday in a letter to manufacturers of spray products to help them address the growing number of patients who have been infected by the COVID virus.
“There is a growing need for a spray that is safe and effective in treating patients who are infected with COVID,” the letter says.
It also advises sprayers to monitor patients for symptoms, particularly those of severe diarrhea, and to use a low dose of the spray to help reduce the risk of exposure to other people.
According to the CDC, about 1 in every 6,000 people in the United States has been infected with the COID-19 coronavirus, and about 10 percent of those people are hospitalized.
Although COVID does not appear to be spreading in the U.S., the agency has been inundated with patients.
In March, it received more than 11 million cases of COVID.
In addition, the U and Canadian governments have stepped up efforts to find new treatment options for the virus.
On Thursday, the CDC issued its own guidance on the effectiveness of spray treatments for patients with COID.
Spray treatments can help to prevent the spread of COID by killing bacteria and viruses, but they also can increase the risk that people who are ill will be exposed to others.
That increased exposure could increase the virus’s spread, potentially increasing the chances of the virus making its way to people in close contact with other people or the environment.
While it may seem counterintuitive to spray patients with a spray, that strategy may prove to be effective, the agency says.
Sprays can also help people with other health conditions to stop spreading the virus, including those who have weakened immune systems, who have suffered from chronic illness or injuries, or who are pregnant.
If a spray treatment is effective, it could provide patients with the right tools to help prevent further spread of the COIDS.
More stories from the top: